Clinical trial
Routine Application of Ostenil® Mini in Patients with Rhizarthrosis
NCT03879434 is registered in ClinicalTrials.gov with TRB Chemedica AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Routine Application of Ostenil® Mini in Patients with Rhizarthrosis
- Lead sponsor
- TRB Chemedica AG
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 17, 2019
- Completion date
- May 16, 2024
- Enrollment
- 110 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
rhizarthrosis